Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare

MIGDAL HA’EMEQ, Israel, Aug. 30, 2017 (GLOBE NEWSWIRE) — Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products, today announced that it has acquired all rights pertaining to five nutritional products from Union Springs Healthcare, LLC, a company founded by renowned health care entrepreneur, Roger Griggs. The products […]

Improved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi- Year, Real-World Retrospective Study

New Retrospective Study to be Presented at The American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting January 13-15, 2017 in Washington DC BALTIMORE, Jan. 10, 2017 (GLOBE NEWSWIRE) — Up to 75 percent of individuals with Attention Deficit Hyperactivity Disorder (ADHD) experience emotional dysregulation, according to Research in Developmental Disabilities. Emotional dysregulation […]

VAYA Pharma CEO featured in Baltimore Business Journal

VAYA Pharma’s CEO Rob Crim spent five minutes with the Baltimore Business Journal digital editor, Jonathan Munshaw, to share information about VAYA Pharma’s products, the company’s growth and his daily responsibilities.  Currently, the majority of Rob’s time is focused on stimulating awareness of the company’s products – Vayarin, Vayacog and Vayarol – among patients and […]

Rob Crim featured on WYPR’s “Why Baltimore”

VAYA Pharma CEO Rob Crim was recently featured on WYPR’s “Why Baltimore,” hosted by Shannon Landwehr, President & CEO of the Economic Alliance of Greater Baltimore. In this segment, Rob discusses the reasons behind the company’s recent move to the University of Maryland BioPark, including Baltimore’s reputation for being a catalyst in innovation, proximity to […]